| Literature DB >> 34957341 |
Emmanuel Uche1, Samuel Nnamdi Marcus1, Lionel Effiom2, Chijioke Okoronkwo3.
Abstract
The pervasive effects of the novel coronavirus (COVID-19) have put the world to test. Its effects permeate all facets of life including healthcare services and food supplies. However, most empirical studies failed to investigate its effects on the prices of food and healthcare services, which by all standards, are essential commodities. On this background, this study evaluates the impact of COVID-19 reported cases and lockdown stringency measures on the food and healthcare prices in the six (6) worst-affected countries. For empirical purposes, daily prices of food and healthcare services between 22nd January and 31st December 2020 were regressed against daily cases of COVID-19 and lockdown stringency measures within the dynamic autoregressive distributed lag procedure. Empirical evidences reveal that prices of healthcare and food are cointegrated with COVID-19 cases and lockdown measures in all the selected countries except Italy. Equally, healthcare and food prices reinforced itself in the long-run in the US, the UK and France. Furthermore, COVID-19 cases lead to significant increases in food and healthcare prices in the US, whereas, food and healthcare prices in France and UK declined significantly as COVID-19 cases mount. Conversely, food and healthcare prices declined significantly in the US and soar in France and the UK in reactions to COVID-19 new cases. Likewise, government stringency measures and containment health measures contributed significantly to healthcare and food price hike in the US and France respectively. Meanwhile, healthcare and food prices in the other selected countries remained unaffected even as the pandemic ravages. Following this empirical discoveries, relevant policy guidelines have been communicated.Entities:
Keywords: COVID-19; Containment health index; Dynamic ARDL; Food prices; Government stringency measure; Healthcare prices
Year: 2021 PMID: 34957341 PMCID: PMC8691956 DOI: 10.1016/j.heliyon.2021.e08656
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Data description and sources.
| Variable Notation | Series | Unit of measurement | Source |
|---|---|---|---|
| CVC | COVID-19 reported Cases | Daily recorded cases | Our World in Data. |
| CVNC | COVID-19 New Cases | New cases recorded on daily basis | Our World in Data. |
| GSI | Government Stringency Index | Composite policy indicator based on nine policy indicators rescaled to a value from 0 to 100 (100 = strictest). | Our World in Data. |
| CNHI | Containment and Health Index | Composite policy indicator based on thirteen policy indicators rescaled to a value from 0 to 100 (100 = strictest). | Our World in Data. |
| FDP | Food Prices | Consumer Price Index (CPI) for Food and non-alcoholic beverages | Country Harmonized Index and Weights - International Financial Statistics (IFS). |
| HCP | Healthcare Prices | Consumer Price Index (CPI) for Healthcare | Country Harmonized Index and Weights - International Financial Statistics (IFS). |
Note: All the data sets are available and freely obtainable in public data repositories.
Summary statistics.
| Variable | Mean | Std. Dev. | Skewness | Kurtosis | Jarque-Bera |
|---|---|---|---|---|---|
| FDP | 3.82 | 0.08 | -0.23 | 2.32 | 9.16∗∗ |
| HLP | 4.23 | 0.08 | 0.14 | 2.21 | 9.21∗∗ |
| CVC | 14.28 | 2.97 | -2.46 | 8.86 | 765.7∗∗∗ |
| CVnC | 10.26 | 2.15 | -2.97 | 12.67 | 1681∗∗∗ |
| GSI | 4.12 | 0.46 | -4.07 | 19.28 | 4324∗∗∗ |
| CnHI | 4.07 | 0.38 | -4.08 | 19.44 | 4399∗∗∗ |
| FDP | 3.46 | 0.07 | 0.12 | 2.16 | 9.95∗∗∗ |
| HLP | 3.33 | 0.06 | 0.33 | 2.31 | 12.21∗∗∗ |
| CVC | 12.26 | 1.91 | -2.83 | 14.26 | 2095∗∗∗ |
| CVnC | 7.48 | 1.82 | -0.23 | 3.14 | 3.01 |
| GSI | 4.16 | 0.25 | -0.58 | 4.63 | 52.97∗∗∗ |
| CnHI | 4.14 | 0.18 | -1.08 | 8.17 | 415∗∗∗ |
| FDP | 3.54 | 0.07 | -0.01 | 1.99 | 12.93∗∗∗ |
| HLP | 3.16 | 0.06 | 0.35 | 2.41 | 10.80∗∗∗ |
| CVC | 12.11 | 2.64 | -2.28 | 8.85 | 704∗∗∗ |
| CVnC | 7.64 | 2.28 | -1.09 | 4.49 | 89.78∗∗∗ |
| GSI | 4.06 | 0.39 | -2.04 | 9.27 | 715∗∗∗ |
| CnHI | 4.06 | 0.29 | -2.93 | 14.51 | 2131∗∗∗ |
| FDP | 3.41 | 0.07 | 0.44 | 3.73 | 18.05∗∗∗ |
| HLP | 3.69 | 0.08 | 0.05 | 2.56 | 2.74 |
| CVC | 11.86 | 2.88 | -2.10 | 6.75 | 431∗∗∗ |
| CVnC | 7.59 | 2.32 | -1.47 | 5.56 | 208∗∗∗ |
| GSI | 4.03 | 0.58 | -2.33 | 6.70 | 482∗∗∗ |
| CnHI | 3.94 | 0.41 | -2.31 | 6.79 | 485∗∗∗ |
| FDP | 6.37 | 0.15 | -0.36 | 2.51 | 9.82∗∗ |
| HLP | 6.53 | 0.16 | -0.13 | 2.36 | 5.96∗ |
| CVC | 12.62 | 2.80 | -2.24 | 7.62 | 520∗∗∗ |
| CVnC | 8.58 | 1.84 | -2.57 | 10.06 | 960∗∗∗ |
| GSI | 4.05 | 0.33 | -1.53 | 9.30 | 616∗∗∗ |
| CnHI | 4.06 | 0.26 | -3.01 | 21.43 | 4717∗∗∗ |
| FDP | 6.28 | 0.23 | 0.63 | 2.43 | 23.78∗∗∗ |
| HLP | 6.13 | 0.17 | 0.16 | 2.13 | 10.35∗∗∗ |
| CVC | 12.05 | 1.92 | -3.25 | 16.90 | 2875∗∗∗ |
| CVnC | 7.58 | 1.34 | -1.16 | 11.44 | 938∗∗∗ |
| GSI | 4.14 | 0.19 | -1.92 | 8.74 | 583∗∗∗ |
| CnHI | 4.11 | 0.13 | -3.09 | 18.70 | 3478∗∗∗ |
Note: The Table provides a summary for all the variable in all the selected countries in terms of average, spread and normality. ∗∗∗, ∗∗, ∗ indicate that the variables are not normally distributed leading to the rejection of null hypothesis of normality at 1%, 5% and 10% levels of significance respectively. All variables are expressed in their logarithmic values except FDP and HLP that are in their original index value.
Unit-tests result.
| Series | Augmented Dickey-Fuller (ADF) | Philips-Perron (P–P) | ||||
|---|---|---|---|---|---|---|
| ADF | ADF | Remarks | P–P | P–P | Remarks | |
| FDP | -1.61 | -16.00∗∗∗ | Order-one | -2.48 | -17.09∗∗∗ | Order-one |
| HLP | -1.60 | -15.86∗∗∗ | Order-one | -2.10 | -17.03∗∗∗ | Order-one |
| LCVC | -2.41 | -3.08∗∗ | Order-one | -4.40∗∗∗ | - | Order-zero |
| LCVNC | -7.68∗∗∗ | - | Order-zero | -6.03∗∗∗ | - | Order-zero |
| LGSI | -3.43∗∗ | - | Order-zero | -3.24∗∗ | - | Order-zero |
| LCNHI | -5.11∗∗∗ | - | Order-zero | -4.29∗∗∗ | - | Order-zero |
| FDP | -1.24 | -15.80∗∗∗ | Order-one | -1.88 | -16.89∗∗∗ | Order-one |
| HLP | -1.63 | -15.86∗∗∗ | Order-one | -2.20 | -16.91∗∗∗ | Order-one |
| LCVC | -4.50∗∗∗ | - | Order-zero | -4.46∗∗∗ | - | Order-zero |
| LCVNC | -1.99 | -22.03∗∗∗ | Order-one | -2.58 | -21.48∗∗∗ | Order-one |
| LGSI | -3.25∗∗ | - | Order-zero | -3.01∗∗ | - | Order-zero |
| LCNHI | -3.19∗∗ | - | Order-zero | -3.12∗∗ | - | Order-zero |
| FDP | -1.47 | -15.84∗∗∗ | Order-one | -1.95 | -17.01∗∗∗ | Order-one |
| HLP | -1.33 | -15.91∗∗∗ | Order-one | -2.04 | -17.02∗∗∗ | Order-one |
| LCVC | -3.59∗∗∗ | - | Order-zero | -4.31∗∗∗ | - | Order-zero |
| LCVNC | -2.51 | -12.35∗∗∗ | Order-one | -4.77∗∗∗ | - | Order-zero |
| LGSI | -2.72 | -11.07∗∗∗ | Order-one | -2.66 | -18.14∗∗∗ | Order-one |
| LCNHI | -5.13∗∗∗ | - | Order-zero | -4.89∗∗∗ | - | Order-zero |
| FDP | -1.02 | -15.79∗∗∗ | Order-one | -1.62 | -16.88∗∗∗ | Order-one |
| HLP | -1.32 | -15.87∗∗∗ | Order-one | -2.00 | -16.91∗∗∗ | Order-one |
| LCVC | -7.40∗∗∗ | - | Order-zero | -6.29∗∗∗ | - | Order-zero |
| LCVNC | -3.97∗∗∗ | - | Order-zero | -1.60 | -23.06∗∗∗ | Order-one |
| LGSI | -2.55 | -3.99∗∗∗ | Order-one | -2.90∗∗ | - | Order-zero |
| LCNHI | -2.25 | -9.21∗∗∗ | Order-one | -2.47 | -14.88∗∗∗ | Order-one |
| FDP | -1.07 | -15.77∗∗∗ | Order-one | -1.81 | -16.88∗∗∗ | Order-one |
| HLP | -1.54 | -15.84∗∗∗ | Order-one | -2.05 | -16.90∗∗∗ | Order-one |
| LCVC | -3.12∗∗ | - | Order-zero | -3.39∗∗ | - | Order-zero |
| LCVNC | -7.17∗∗∗ | - | Order-zero | -9.60∗∗∗ | - | Order-zero |
| LGSI | -2.86 | -17.57∗∗∗ | Order-one | -2.71 | -18.19∗∗∗ | Order-one |
| LCNHI | -2.99∗∗ | - | Order-zero | -2.91 | -18.07∗∗∗ | Order-one |
| FDP | -1.36 | -14.41∗∗∗ | Order-one | -1.50 | -15.74∗∗∗ | Order-one |
| HLP | -1.79 | -14.69∗∗∗ | Order-one | -2.02 | -15.69∗∗∗ | Order-one |
| LCVC | -7.53∗∗∗ | - | Order-zero | -11.45∗∗∗ | - | Order-zero |
| LCVNC | -3.49∗∗∗ | - | Order-zero | -6.28∗∗∗ | - | Order-zero |
| LGSI | -4.76∗∗∗ | - | Order-zero | -4.77∗∗∗ | - | Order-zero |
| LCNHI | -5.91∗∗∗ | - | Order-zero | -5.91∗∗∗ | - | Order-zero |
Note: ∗∗∗ and ∗∗ signify the rejection of the null of stationarity at 1% and 5% significance levels respectively.
Cointegration test for covid-19 effects on food and healthcare prices.
| The USA | Italy | France | The UK | Russia | Turkey | |
|---|---|---|---|---|---|---|
| F-Statistics | 13.27∗∗∗ | 1.40 | 2.67∗∗ | 4.56∗∗∗ | 2.07∗ | 1.24 |
| F-Statistics | 11.74∗∗ | 1.38 | 2.65∗∗ | 2.52∗∗ | 1.36 | 3.01∗∗ |
Note: The table summarizes the DARDL bounds tests. ∗∗∗, ∗∗ and ∗ indicate rejection of null hypothesis of no cointegration at 1%, 5% and 10% significant levels respectively.
Results from the Dynamic ARDL estimation (Dependent variable: Healthcare Prices).
| Countries | The USA | Italy | France | The UK | Russia | Turkey |
|---|---|---|---|---|---|---|
| 0.397∗∗∗ | 0.157∗∗ | -0.018 | 0.117∗∗ | 0.068 | 0.151∗∗ | |
| 0.011∗∗∗ | - | -0.002∗∗ | -0.002∗∗ | - | -0.001 | |
| 0.065∗∗ | -0.044∗∗ | -0.009 | -0.094∗∗∗ | -0.036 | -0.034 | |
| -0.007∗∗∗ | - | 0.001 | 0.001 | - | -0.002 | |
| -0.004 | -0.005∗∗ | 0.001 | 0.001 | 0.001 | 0.002 | |
| 0.351∗∗∗ | - | -0.030∗∗ | 0.012 | - | 0.035 | |
| 0.066 | -0.050 | -0.046∗∗ | 0.004 | -.119 | 0.049 | |
| -0.453∗∗∗ | - | 0.063∗∗ | -0.012 | - | -0.085 | |
| -0.063 | 0.104 | 0.085∗∗∗ | -0.009 | -0.025 | -0.170 | |
| -0.03∗∗ | -0.02∗ | -0.03∗∗ | -0.03∗ | -0.01∗ | 0.02∗ | |
| 0.52 | 0.61 | 0.72 | 0.45 | 0.34 | 0.38 | |
| 10.21∗∗∗ | 2.42∗∗ | 1.89∗ | 2.66∗∗∗ | 2.17∗∗ | 2.27∗∗ | |
| 5000 | 5000 | 5000 | 5000 | 5000 | 5000 | |
| 0.421∗∗∗ | 0.140∗∗ | -0.046 | 0.150∗∗∗ | 0.004 | 0.067 | |
| 0.011∗∗∗ | - | -0.003∗∗ | -0.003∗∗∗ | -0.001 | - | |
| 0.050 | -0.057∗∗∗ | -0.013 | -0.102∗∗∗ | -0.035 | -0.048 | |
| -0.006∗∗∗ | - | 0.001 | 0.001∗∗ | -0.003 | - | |
| -0.003 | -0.006∗ | 0.001 | 0.001 | -1.480 | 0.002 | |
| 0.357∗∗∗ | - | -0.031∗ | 0.015∗∗ | -0.010 | - | |
| 0.084 | -0.040 | -0.050∗∗ | 0.012 | -0.122 | 0.025 | |
| -0.455∗∗∗ | - | 0.070∗∗ | -0.015 | 0.020 | - | |
| -0.085 | 0.095 | 0.097∗∗∗ | -0.019 | -0.027 | -0.107 | |
| -0.33∗∗ | -0.01∗ | -0.02∗ | -0.03∗∗∗ | -0.01∗ | -0.01∗ | |
| 0.52 | 0.62 | 0.53 | 0.84 | 0.15 | 0.06 | |
| 11.11∗∗∗ | 2.24∗∗ | 1.75∗ | 4.25∗∗∗ | 2.91∗∗∗ | 1.19∗ | |
| 5000 | 5000 | 5000 | 5000 | 5000 | 5000 | |
Note: ∗∗∗, ∗∗ and ∗ symbolize that the null hypothesis is rejected at 1%, 5% and 10% significant levels respectively. Panels A and B provide long- and short-run estimates for covid-19 healthcare prices nexus and covid-19 food prices nexus, respectively. ECT(-1) implies error correction term that shows the speed of adjustment to long-run equilibrium.
Figure 1LCVC and HLP - USA.
Figure 2LCVNC and HLP - USA.
Figure 3LGSI and HLP – USA.
Figure 4LCNHI and HLP - USA.
Figure 5LCVC and FDP - USA.
Figure 6LCVNC and FDP - USA.
Figure 7LGSI and FDP - USA.
Figure 8LCNHI and FDP - USA.
Figure 9CUSUM and CUSUM2 graphs for models 1 and 2 – The US.
Post estimation/diagnostic tests.
| Series | F-Stat (Model 1) | F-Stat (Model 2) |
|---|---|---|
| Autocorrelation (Breusch-Godfrey LM test) | 2.64 (0.10) | 2.43 (0.12) |
| Autocorrelation (Durbin's alternative test) | 2.59 (0.11) | 2.38 (0.17) |
| Homoscedasticity (White's test) | 45.56 (0.10) | 38.83 (0.30) |
| Autocorrelation (Breusch-Godfrey LM test) | 3.51 (0.15) | 4.62 (0.13) |
| Autocorrelation (Durbin's alternative test) | 3.49 (0.11) | 3.17 (0.12) |
| Homoscedasticity (White's test) | 11.45 (0.24) | 9.14 (0.42) |
| Autocorrelation (Breusch-Godfrey LM test) | 1.41 (0.23) | 1.02 (0.37) |
| Autocorrelation (Durbin's alternative test) | 1.34 (0.25) | 0.97 (0.41) |
| Homoscedasticity (White's test) | 17.37 (0.39) | 34.17 (0.10) |
| Autocorrelation (Breusch-Godfrey LM test) | 3.13 (0.12) | 3.74 (0.11) |
| Autocorrelation (Durbin's alternative test) | 3.10 (0.12) | 3.72 (0.12) |
| Homoscedasticity (White's test) | 12.74 (0.13) | 17.39 (0.12) |
| Autocorrelation (Breusch-Godfrey LM test) | 1.42 (0.23) | 1.91 (0.12) |
| Autocorrelation (Durbin's alternative test) | 1.37 (0.24) | 1.86 (0.13) |
| Homoscedasticity (White's test) | 65.17 (0.43) | 66.09 (0.40) |
| Autocorrelation (Breusch-Godfrey LM test) | 2.37 (0.12) | 2.70 (0.10) |
| Autocorrelation (Durbin's alternative test) | 2.30 (0.13) | 2.62 (0.10) |
| Homoscedasticity (White's test) | 82.74 (0.10) | 46.70 (0.74) |
Note: The table summarizes the post estimation diagnostic tests. Probability values are in ().